Precision Medicine Analysis Report 2026: A $237.28 Billion Market by 2031 - Strategic Pharma-Big-Tech Alliances Speeding Precision Drug Discovery

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

• Asia-Pacific is the fastest-growing region with a 14.12% CAGR

  80% confidence

• More than 15 FDA clearances since 2024 have tied targeted drugs to specific biomarker tests, widening the addressable patient pool for precision oncology

  80% confidence

• Next-generation sequencing captured 33.78% of the precision medicine market share in 2025

  80% confidence

• Guardant Health's Shield blood test detects colorectal cancer with 83% sensitivity in average-risk adults

  80% confidence

• North America led the precision medicine market with a 47.85% revenue share in 2025

  80% confidence

• SomaLogic measures 10,000 proteins from a microliter sample, producing high-density data that AI models translate into early disease risk scores

  80% confidence

• The Precision Medicine market size in 2026 is estimated at USD 125.71 billion, growing from 2025 value of USD 110.68 billion with 2031 projections showing USD 237.28 billion, growing at 13.58% CAGR over 2026-2031

  80% confidence

• China's Human Genome Project 2 plans to sequence 80 million genomes, creating the world's largest reference panel for variant interpretation

  80% confidence

• Artificial intelligence and machine learning is the fastest-growing segment at a 17.62% CAGR

  80% confidence

• Japan has committed to analyze 100,000 cancer genomes under a national program to guide targeted therapy development

  80% confidence